These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3094557)

  • 1. Inhibitory effects of Ge-132 (carboxyethyl germanium sesquioxide) derivatives on enkephalin-degrading enzymes.
    Komuro T; Kakimoto N; Katayama T; Hazato T
    Biotechnol Appl Biochem; 1986 Oct; 8(5):379-86. PubMed ID: 3094557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of enkephalin-degrading enzymes from longitudinal muscle layer of bovine small intestine. Enzyme inhibition by arphamenine A.
    Hazato T; Shimamura M; Kase R; Iijima M; Katayama T
    Biochem Pharmacol; 1985 Sep; 34(17):3179-83. PubMed ID: 3899121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
    Shimamura M; Kawamuki K; Hazato T
    J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
    Hazato T; Kase R; Ueda H; Takagi H; Katayama T
    Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
    Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
    Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effect of novel organogermanium compound, GE-132.
    Hachisu M; Takahashi H; Koeda T; Sekizawa Y
    J Pharmacobiodyn; 1983 Nov; 6(11):814-20. PubMed ID: 6366183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and characterization of a dipeptidyl aminopeptidase that degrades enkephalins from monkey brain.
    Hazato T; Inagaki-Shimamura M; Katayama T; Yamamoto T
    Biochem Biophys Res Commun; 1982 Mar; 105(2):470-5. PubMed ID: 7046748
    [No Abstract]   [Full Text] [Related]  

  • 10. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
    Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
    Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
    Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
    Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.
    Hernandez JF; Soleilhac JM; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1988 Sep; 31(9):1825-31. PubMed ID: 2900898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomenclature for enkephalin degrading peptidases.
    Hersh LB
    Life Sci; 1986 Mar; 38(13):1151-3. PubMed ID: 3515092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
    Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
    J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII.
    Yamamoto Y; Hashimoto J; Shimamura M; Yamaguchi T; Hazato T
    Peptides; 2000 Apr; 21(4):503-8. PubMed ID: 10822105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enkephalin metabolism in brain and its inhibition.
    Schwartz JC; De La Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):665-71. PubMed ID: 6298893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and analgesic mechanism of the opioid analgesic neuropeptide, kyotorphin (Tyr-Arg)].
    Shiomi H; Ueda H
    Yakugaku Zasshi; 1985 Jun; 105(6):531-41. PubMed ID: 2999373
    [No Abstract]   [Full Text] [Related]  

  • 19. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation.
    Marchner H; Haraldsson S; Lundberg S
    Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spinorphin, a new inhibitor of enkephalin-degrading enzymes derived from the bovine spinal cord].
    Nishimura K; Hazato T
    Masui; 1993 Oct; 42(10):1497-503. PubMed ID: 8230703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.